MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX

Código QR

MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX

Objective To investigate the effect of miRNA-495 on the proliferation and apoptosis of acute myeloid leukemia (AML) cells with mixed lineage leukemia (MLL) gene rearrangement. Methods Ten patients diagnosed with AML with MLL-AF9 fusion gene positive (6 males, 4 females, mean age of 39.37±2.71 years)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	YANG Rui, NING Jing, JING Lijuan, WANG Hainan, CUI Lijuan
Formato:	article
Lenguaje:	ZH
Publicado:	Editorial Office of Journal of Third Military Medical University 2021
Materias:	acute myeloid leukemia mll-af9 mirna-495 serine/threonine/tyrosine interacting protein cell proliferation Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b2a3405a20e6413a88253e40053d99e8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang Sheng, et al.
Publicado: (2020)

Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia
por: Yundeok Kim, et al.
Publicado: (2021)

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev B, et al.
Publicado: (2016)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà G, et al.
Publicado: (2019)

Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
por: Tan BK, et al.
Publicado: (2021)

CHRONIC MYELOID LEUKEMIA - CLINICAL AND IMMUNOLOGICAL PECULIARITIES IN ADULT PATIENTS
por: O. V. Smirnova
Publicado: (2012)

Myeloid sarcoma: an uncommon presentation of myeloid neoplasms; a case series of 4 rare cases reported in a tertiary care institute
por: Toyaja Jadhav, et al.
Publicado: (2021)

An Aspartate-Specific Solute-Binding Protein Regulates Protein Kinase G Activity To Control Glutamate Metabolism in Mycobacteria
por: Nabanita Bhattacharyya, et al.
Publicado: (2018)

Light limitation inducing overcompensatory growth of cyanobacteria and function of serine/threonine kinase (STK) genes involved
por: Wei Dai, et al.
Publicado: (2021)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
por: Gordon D, et al.
Publicado: (2021)

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Shadi Esmaeili, et al.
Publicado: (2021)

Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
por: Brittany M. Smith, et al.
Publicado: (2021)

ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway
por: Feng,Yubin, et al.
Publicado: (2019)

The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review
por: Muhammad Darwin Prenggono, et al.
Publicado: (2021)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Bilal Abdulmawjood, et al.
Publicado: (2021)

Hipoxemia espuria por hiperleucocitosis: Reporte de un caso y revisión de la literatura
por: Florenzano V,Pablo, et al.
Publicado: (2012)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: You Jiang, et al.
Publicado: (2021)

Conventional Cytogenetic and Molecular Analysis in Acute Myeloid Leukemia (AML) and Their Association with Overall Survival
por: Shakeri S., et al.
Publicado: (2021)

Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1
por: Yao-hua Lu, et al.
Publicado: (2021)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)

Resultados de profilaxis con itraconazol 800 mg/día vía oral en adultos con leucemia aguda y neutropenia de alto riesgo: Hospital del Salvador 2006-2008
por: Andrade M,Alejandro, et al.
Publicado: (2011)

IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells
por: Zhang,Feng, et al.
Publicado: (2019)

Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
por: Long-Long Cao, et al.
Publicado: (2021)

PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107
por: Holly Fowle, et al.
Publicado: (2021)

Age- and Gender-Independent Association of XRCC1 Arg399Gln Polymorphism with Chronic Myeloid Leukemia
por: Abdalhabib EK, et al.
Publicado: (2021)

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
por: Briot T, et al.
Publicado: (2017)

Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
por: Wang Sing-Ting, et al.
Publicado: (2021)

Leucemia promielocítica aguda: Resultados del protocolo terapéutico LPA2000, Programa Nacional de Cáncer del Adulto (PANDA), Ministerio de Salud, Chile
por: Undurraga,María Soledad, et al.
Publicado: (2013)

EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE
por: Abdul Ali Wajid, et al.
Publicado: (2018)

Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia
por: Kyoko Ito, et al.
Publicado: (2021)

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
por: Mojdeh Soltani, et al.
Publicado: (2021)

Leucemia mieloide aguda del adulto: Resultados del Protocolo Nacional de Drogas Antineoplásica. Hospital del Salvador 1990-1998
por: Puga L,Barbara, et al.
Publicado: (2000)

IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
por: Taylor A. Harper, et al.
Publicado: (2021)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
por: Nighat Shahbaz, et al.
Publicado: (2020)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
por: Anagnostou T, et al.
Publicado: (2017)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Sayaka Kiso, et al.
Publicado: (2021)

Leucemia mieloide crónica en hemofilia B: Report of one case
por: Larraín A,Camilo
Publicado: (2002)

Resultados en el tratamiento de pacientes con leucemia mieloide aguda no promielocítica en el Hospital Clínico de la Pontificia Universidad Católica entre los años 2010-2014
por: Fuentes,Mónica, et al.
Publicado: (2015)

Leucemia mieloide aguda secundaria a inmunosupresores en una paciente trasplantada de pulmón, una inusual y letal entidad
por: Peña,Camila, et al.
Publicado: (2015)

Circular RNAs in acute myeloid leukemia
por: Vijendra Singh, et al.
Publicado: (2021)